home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Nicotine Improves Survival In Sepsis

  November, 9 2004 9:35
your information resource in human molecular genetics
Nicotine improves survival in a rodent model of sepsis, according to a report in the November issue of Nature Medicine.

During sepsis -- a leading cause of mortality in industrialized societies -- there is an exaggerated inflammatory response that ultimately leads to multiple organ failure and death. Luis Ulloa and his colleagues found that the neurotransmitter acetylcholine inhibits cellular events that are involved in this inflammatory reaction. The action of acetylcholine depends on a receptor that can also bind nicotine and, indeed, nicotine proved to be more efficient in eliciting an anti-inflammatory effect. Moreover, nicotine administration to rodents with sepsis prevented their death.

These results show that acetylcholine is a physiological inhibitor of inflammation and suggest that molecules related to nicotine might be useful for the treatment of sepsis.

Author contact
Luis Ulloa (Center of Immunology and Inflammation, North Shore-LIJ Research Institute, Manhasset, NY, USA)
Tel: + 1 516 562 2315, E-mail: lulloa@nshs.edu

Also available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.